Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

LeukoSite and Oxford Asymmetry collaboration in IBD

Oct. 4, 1996

Promising phase III results with treatment for ulcerative colitis

Oct. 4, 1996

Clinical trial on oral H. pylori vaccine completed

Oct. 4, 1996

GI drugs under development at Takeda

Sep. 27, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Generic dicyclomine HCl now available in the U.S.

Sep. 27, 1996

Clinical trials with Gilead Sciences' GS-840

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...